Elevance Health, US0367521038

Elevance Health stock pre-market at EUR 355.85: plus 0.31 percent

Published on 10/07/2026 at 07:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Elevance Health stock is at EUR 355.85 pre-market at Lang & Schwarz on October 7, 2026, up 0.31 percent versus the prior close. Third-quarter results are scheduled for October 21.

Draufsicht-Arrangement mit Aktienzertifikat, ISIN-Karte US2855211023 und Stethoskop
Elevance Health US2855211023 Flatlay mit Aktienzertifikat ISIN-Karte Stethoskop und medizinischen Utensilien auf Marmor, Illustration mit AI erstellt.

Elevance Health stock is at EUR 355.85 pre-market at 7:48 a.m. CEST on October 7, 2026, according to Lang & Schwarz. The price is up 0.31 percent versus the Lang & Schwarz prior close of EUR 354.75 on October 6, 2026.

Pre-market price

Lang & Schwarz shows a bid of EUR 353.20 and an ask of EUR 358.50. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Elevance Health stock.

Third-quarter results scheduled

Elevance Health said in an October 5, 2026, press release that it will release third-quarter 2026 financial results on October 21 at 6:00 a.m. Eastern Daylight Time. Management is scheduled to discuss the results and its outlook during a conference call at 8:30 a.m. EDT the same day.

The company said the call will be available through a live webcast on its website under the Investors section. A replay is scheduled to be available from 11:30 a.m. EDT on October 21 through the end of November 20, 2026.

Disclaimer...

en | US0367521038 | ELEVANCE HEALTH | boerse | 70251351 | bgmi